查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1498776

尿路感染治療市場，按疾病、藥物類別、配銷通路、國家和地區 - 2024-2032 年行業分析、市場規模、市場佔有率和預測

Urinary Tract Infection Treatment Market, By Disease, By Drug Class, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2023年泌尿道感染治療市場規模為92.3821億美元，2024年至2032年複合年成長率為3.98%。

尿路感染治療市場-市場動態

尿路感染的日益普及和先進的診斷技術預計將推動市場需求

泌尿道感染（UTI）盛行率不斷上升，推動了對有效治療替代方案的需求，這種感染在女性、老年人和慢性病患者中尤其常見，預計將推動市場成長。作為最常見的細菌感染之一，泌尿道感染需要可靠且定期的治療替代方案。較高的診斷率是對泌尿道感染症狀的了解增加以及及時治療的重要性的結果。改進的診斷儀器和公共衛生措施支持早期檢測和治療，從而加速市場擴張。

分子診斷和快速尿液檢測等診斷技術的技術發展提高了診斷泌尿道感染的準確性和速度。這改善了治療效果並推動了用於診斷和治療的醫療設備市場。增加醫療保健支出使獲得醫療設施和泌尿道感染治療變得更加容易，尤其是在發展中國家。由於這些經濟因素，尿路感染治療市場正在不斷成長。此外，政府活動和醫療保健組織對更好的泌尿道感染管理的支持也對市場產生了積極影響。這些措施包括為研究和發展、公共衛生運動和加強醫療基礎設施提供資金。

尿路感染治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2024-2032 年）每年將以 3.98% 左右的複合年成長率成長

根據疾病細分，由於泌尿系統疾病的盛行率不斷上升，預計複雜尿路感染細分市場將在 2023 年顯示最大的市場佔有率。

根據藥物類別細分，由於對腎臟相關疾病治療的高需求，喹諾酮類藥物細分市場將在 2023 年成為領先的藥物類別。

根據配銷通路細分，由於對腎臟和糖尿病疾病治療的高需求，醫院藥房細分市場將在 2023 年成為領先的配銷通路。

按地區分類，由於公司醫療保健支出不斷成長，北美將成為 2023 年的主要收入來源。

尿路感染治療市場-細分分析：

全球尿路感染治療市場根據疾病、藥物類別、配銷通路和地區進行細分。

市場依疾病分為兩類：複雜性泌尿道感染及簡單性泌尿道感染。複雜的尿路感染細分市場佔據主導地位。疾病治療的進步和新設備的採用正在推動該領域的成長。

依藥物類別，市場分為五類：喹諾酮類、BETA-內醯胺類、大環內酯類、氨基糖苷類等。喹諾酮類藥物在市場上佔據主導地位。由於人們對泌尿道感染的了解不斷增加，尋求醫療照護的需求不斷成長，這推動了市場的成長。

根據分銷管道，市場分為三類：零售藥局、網路藥局和醫院藥局。醫院藥房領域在市場中佔據主導地位，預計在預測期內將保持其較高的主導地位。隨著電子商務行業的興起加速了市場的成長，線上藥局預計將以最快的複合年成長率成長。

泌尿道感染治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太、中東和非洲等地區。北美正在主導全球市場。該地區擁有先進的醫療基礎設施，可以輕鬆獲得診斷和治療。由於高額醫療支出和強勁的製藥業，北美擁有最大的市場佔有率。預計亞太地區在預測期內將以最高的速度擴張。

尿路感染治療市場-競爭格局：

泌尿道感染 (UTI) 治療市場競爭激烈，由多家參與 UTI 管理藥物和療法開發、製造和分銷的關鍵參與者組成。公司正致力於開發下一代抗生素和針對多重抗藥性感染的治療方法。例如，葛蘭素史克公司參與了解決抗菌素抗藥性的合作努力，並擁有多種化合物正在進行細菌感染的臨床試驗。

最近的發展：

2022年，Spero Therapeutics Inc.向美國食品藥物管理局（FDA）提交了新藥申請（NDA），並獲得批准用於治療複雜性尿路感染（cUTI）的氫溴酸替比培南片劑。

2022 年，印度領先的學名藥公司 BDR Pharma 推出了比阿培南，用於治療腹內感染和複雜泌尿道感染患者。

目錄

第1章：尿路感染治療市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 依疾病分類的泌尿道感染治療市場片段
    • 按藥物類別分類的泌尿道感染治療市場片段
    • 按配銷通路分類的尿路感染治療市場片段
    • 按國家/地區分類的泌尿道感染治療市場片段
    • 按地區分類的泌尿道感染治療市場片段
  • 競爭洞察

第 3 章：泌尿道感染治療主要市場趨勢

  • 尿路感染治療市場促進因素
    • 市場促進因素的影響分析
  • 尿路感染治療市場限制
    • 市場限制影響分析
  • 尿路感染治療市場機會
  • 尿路感染治療市場未來趨勢

第 4 章：泌尿道感染治療產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：泌尿道感染治療市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：泌尿道感染治療市場格局

  • 2023 年泌尿道感染治療市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：泌尿道感染治療市場 - 依疾病分類

  • 概述
    • 按疾病分類的細分市場佔有率分析
    • 複雜性泌尿道感染
    • 簡單的泌尿道感染

第 8 章：泌尿道感染治療市場 - 依藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 奎諾酮類
    • BETA內醯胺類
    • 大環內酯類
    • 氨基糖苷類
    • 其他

第 9 章：泌尿道感染治療市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 零售藥局
    • 網路藥局
    • 醫院藥房

第 10 章：泌尿道感染治療市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美尿路感染治療主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模與預測（按疾病）
    • 北美市場規模和預測（按藥物類別）
    • 北美市場規模和預測（按配銷通路）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲泌尿道感染治療主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模與預測（按疾病）
    • 歐洲市場規模和預測（按藥物類別）
    • 歐洲市場規模和預測（按配銷通路）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區尿路感染治療主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按疾病）
    • 亞太地區市場規模和預測（按藥物類別）
    • 亞太地區市場規模和預測（按配銷通路）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲尿路感染治療主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按疾病）
    • 拉丁美洲市場規模與預測（按藥物類別）
    • 拉丁美洲市場規模和預測（按配銷通路）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲泌尿道感染治療主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按疾病）
    • 中東和非洲市場規模及預測（按藥物類別）
    • 中東和非洲市場規模及預測（按配銷通路）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 泌尿道感染治療產業

  • 競爭儀表板
  • 公司簡介
    • AbbVie Inc.
    • Pfizer Inc.
    • Johnson & Johnson
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • Roche Holding AG
    • Allergan plc
    • BDR Pharma
    • Bayer AG
    • Bristol-Myers Squibb
    • AstraZeneca plc
    • Novartis International AG
    • Sanofi SA
    • Eli Lilly and Company
    • Spero Therapeutics
    • Paratek Pharmaceuticals
    • Iterum Therapeutics
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV2947

REPORT HIGHLIGHT

Urinary Tract Infection Treatment Market size was valued at USD 9,238.21 Million in 2023, expanding at a CAGR of 3.98% from 2024 to 2032.

Treatment for urinary tract infections (UTIs) usually consists of a mix of prescription drugs, dietary adjustments, and preventative measures. To avoid consequences like kidney infections or repeated infections, proper diagnosis and treatment are essential for UTIs.

Urinary Tract Infection Treatment Market- Market Dynamics

The growing prevalence of urinary infections and advanced diagnostic techniques are expected to propel market demand

The need for efficient treatment alternatives is fueled by the rising prevalence of Urinary Tract infections (UTIs), which are especially common in women, the elderly, and patients with chronic conditions is expected to boost the market growth. Being one of the most prevalent bacterial infections, UTIs require dependable and regular treatment alternatives. Higher diagnosis rates are the result of increased knowledge of UTI symptoms and the significance of prompt treatment. Improved diagnostic instruments and public health initiatives support early detection and treatment, which accelerates market expansion.

The accuracy and speed of diagnosing UTIs are enhanced by technological developments in diagnostic techniques, such as molecular diagnostics and fast urine testing. This improves treatment results and fuels the market for medical devices for diagnosis and treatment. Increasing healthcare spending makes it easier to access medical facilities and UTI treatments, especially in developing nations. The market for UTI treatments is growing because of these economic factors. Additionally, the market is positively impacted by government activities and healthcare organizations' support for better UTI management. These initiatives include funding for research and development, public health campaigns, and enhanced healthcare infrastructure.

Urinary Tract Infection Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 3.98% over the forecast period (2024-2032)

Based on Disease segmentation, the complicated UTIs segment was predicted to show maximum market share in the year 2023, owing to the growing prevalence of urinary disorders.

Based on Drug Class segmentation, the Quinolones segment was the leading Drug Class in 2023, due to high demand for kidney-related disease treatment.

Based on Distribution Channel segmentation, the hospital pharmacies segment was the leading Distribution Channel in 2023, owing to the high demand for treatment of kidney and diabetic disorders.

On the basis of region, North America was the leading revenue generator in 2023, owing to growing healthcare spending by companies.

Urinary Tract Infection Treatment Market- Segmentation Analysis:

The Global Urinary Tract Infection Treatment Market is segmented on the basis of Disease, Drug Class, Distribution Channel, and Region.

The market is divided into two categories based on Disease: complicated UTIs and uncomplicated UTIs. The complicated UTIs segment dominates the market. Advancement in disease treatment and the adoption of new devices are fueling the segment's growth.

The market is divided into five categories based on the Drug Class: quinolones, beta-lactams, macrolides, aminoglycosides, and others. The quinolones segment dominates the market. The growing demand from people seeking medical attention owing to increased knowledge regarding UTIs is contributing to market growth.

The market is divided into three categories based on Distribution channels: retail pharmacies, online pharmacies, and hospital pharmacies. The hospital pharmacies segment dominates the market and is expected to maintain its high dominance during the forecast period. Online pharmacies is expected to grow at the fastest CAGR with the rising e-commerce sector which is accelerating the growth of the market.

Urinary Tract Infection Treatment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America is dominating the global market. The region has advanced healthcare infrastructure that supports easy access to diagnosis and treatment. North America has the largest market share due to high healthcare expenditure and the robust pharmaceutical industry. Asia Pacific is estimated to expand at the highest rate over the forecast period.

Urinary Tract Infection Treatment Market- Competitive Landscape:

The Urinary Tract Infection (UTI) treatment market is significantly competitive and comprises several key players involved in the development, manufacturing, and distribution of pharmaceuticals and therapies for UTI management. Companies are engaged in research to develop next-generation antibiotics and treatments aimed at multidrug-resistant infections. For example, GSK plc is involved in collaborative efforts to tackle antimicrobial resistance and has several compounds in clinical trials for bacterial infections.

Recent Developments:

In 2022, Spero Therapeutics Inc. offered an NDA to the US Food and Drug Administration (FDA) and got approval for tebipenem HBr tablets for the treatment of complicated urinary tract infections (cUTI).

In 2022, BDR Pharma, a leading generic pharmaceutical company in India, introduced biapenem to treat patients with intra-abdominal infections, and complex UTIs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET KEY PLAYERS

  • AbbVie Inc.
  • Pfizer Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Roche Holding AG
  • Allergan plc
  • BDR Pharma
  • Bayer AG
  • Bristol-Myers Squibb
  • AstraZeneca plc
  • Novartis International AG
  • Sanofi S.A.
  • Eli Lilly and Company
  • Spero Therapeutics
  • Paratek Pharmaceuticals
  • Iterum Therapeutics
  • Others

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DISEASE- MARKET ANALYSIS, 2019-2032

  • Complicated UTIs
  • Uncomplicated UTIs

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2019-2032

  • Quinolones
  • Beta lactams
  • Macrolides
  • Aminoglycosides
  • Others

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019-2032

  • Retail pharmacies
  • Online pharmacies
  • Hospital pharmacies

GLOBAL URINARY TRACT INFECTION TREATMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Urinary Tract Infection Treatment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Urinary Tract Infection Treatment Market Snippet by Disease
    • 2.1.2. Urinary Tract Infection Treatment Market Snippet by Drug Class
    • 2.1.3. Urinary Tract Infection Treatment Market Snippet by Distribution Channel
    • 2.1.4. Urinary Tract Infection Treatment Market Snippet by Country
    • 2.1.5. Urinary Tract Infection Treatment Market Snippet by Region
  • 2.2. Competitive Insights

3. Urinary Tract Infection Treatment Key Market Trends

  • 3.1. Urinary Tract Infection Treatment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Urinary Tract Infection Treatment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Urinary Tract Infection Treatment Market Opportunities
  • 3.4. Urinary Tract Infection Treatment Market Future Trends

4. Urinary Tract Infection Treatment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Urinary Tract Infection Treatment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Urinary Tract Infection Treatment Market Landscape

  • 6.1. Urinary Tract Infection Treatment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Urinary Tract Infection Treatment Market - By Disease

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Disease, 2024 & 2032 (%)
    • 7.1.2. Complicated UTIs
    • 7.1.3. Uncomplicated UTIs

8. Urinary Tract Infection Treatment Market - By Drug Class

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Drug Class, 2024 & 2032 (%)
    • 8.1.2. Quinolones
    • 8.1.3. Beta lactams
    • 8.1.4. Macrolides
    • 8.1.5. Aminoglycosides
    • 8.1.6. Others

9. Urinary Tract Infection Treatment Market - By Distribution Channel

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 9.1.2. Retail pharmacies
    • 9.1.3. Online pharmacies
    • 9.1.4. Hospital pharmacies

10. Urinary Tract Infection Treatment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Urinary Tract Infection Treatment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Urinary Tract Infection Treatment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Urinary Tract Infection Treatment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Urinary Tract Infection Treatment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Urinary Tract Infection Treatment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Disease, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Drug Class, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Urinary Tract Infection Treatment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. AbbVie Inc.
    • 11.2.2. Pfizer Inc.
    • 11.2.3. Johnson & Johnson
    • 11.2.4. GlaxoSmithKline plc
    • 11.2.5. Merck & Co., Inc.
    • 11.2.6. Roche Holding AG
    • 11.2.7. Allergan plc
    • 11.2.8. BDR Pharma
    • 11.2.9. Bayer AG
    • 11.2.10. Bristol-Myers Squibb
    • 11.2.11. AstraZeneca plc
    • 11.2.12. Novartis International AG
    • 11.2.13. Sanofi S.A.
    • 11.2.14. Eli Lilly and Company
    • 11.2.15. Spero Therapeutics
    • 11.2.16. Paratek Pharmaceuticals
    • 11.2.17. Iterum Therapeutics
    • 11.2.18. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Urinary Tract Infection Treatment Market: Disease Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease
  • TABLE Global Urinary Tract Infection Treatment Market, by Disease 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Drug Class Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Urinary Tract Infection Treatment Market, by Drug Class 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Distribution Channel Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global Urinary Tract Infection Treatment Market, by Distribution Channel 2019-2032 (USD Million)
  • TABLE Urinary Tract Infection Treatment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Urinary Tract Infection Treatment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE North America Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Europe Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Asia Pacific Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Latin America Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Disease, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Drug Class, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Urinary Tract Infection Treatment Market, by Distribution Channel, 2019-2032 (USD Million)